Skip to main content
. 2021 Feb 25;13(5):967. doi: 10.3390/cancers13050967

Table 2.

Statistical comparison of the mean physiological parameter indices computed for different kinds of tissues (HM, AD, CA) and regarding different characteristics (neoadjuvant therapy, tumor classification); blue = no statistical difference p > 0.05; red = * p ≤ 0.05; yellow = ** p ≤ 0.01; white = *** p ≤ 0.001. The symbol # denotes independent datasets.

Tissue Tissue-/Tumor Classification TWI OHI NIR-PI StO2
CA #CA: (y)pT1-(y)pT2 vs. (y)pT3-(y)pT4 (0.78/0.68) (0.59/0.56) (0.32/0.2) * (0.37/0.31)0.061
- #CA: ypT1-ypT2 vs. ypT3-ypT4 (0.79/0.65) * (0.46/0.56) (0.35/0.14) * (0.38/0.31)
CA vs. HM CA ((y)pT) vs. HM (0.76/0.65) * (0.59/0.42) *** (0.22/0.26) (0.34/0.24) ***
- CA (pT) vs. HM (0.76/0.63) ** (0.65/0.44) *** (0.2/0.26) (0.34/0.23) **
- CA (ypT) vs. HM (0.76/0.69)0.082 (0.55/0.39) ** (0.3/0.32) (0.34/0.26) **
- pT1-pT2 CA vs. HM (0.67/0.62) (0.68/0.46) ** (0.19/0.27) (0.35/0.26)0.055
- ypT1-ypT2 CA vs. HM (0.79/0.69) * 0.46/0.33) (0.35/0.32)0.093 (0.38/0.24) ***
- pT3-pT4 CA vs. HM (0.76/0.64) * (0.6/0.43) ** (0.21/0.24) (0.31/0.23) *
- ypT3-ypT4 CA vs. HM (0.65/0.71) (0.56/0.42) * (0.14/0.31) ** (0.31/0.27)
AD #AD vs. HM (from (y)pT1-(y)pT2) (0.71/0.66) (0.55/0.4) * (0.32/0.31) (0.33/0.26)
- #AD vs. HM (from (y)pT3-(y)pT4) (0.71/0.65) (0.55/0.43) * (0.32/0.27) (0.33/0.24) *
- #AD vs. HM (from ypT) (0.71/0.69) (0.55/0.39) * (0.32/0.32) (0.33/0.26)
- AD vs. HM (0.71/0.65) (0.55/0.42)0.052 (0.32/0.27) (0.33/0.24) *
- #AD vs. ypT1-ypT2 CA (0.71/0.79) (0.55/0.46) (0.32/0.35) (0.33/0.38)
- #AD vs. HM (from ypT1-ypT2) (0.71/0.69) (0.55/0.33) * (0.32/0.32) (0.33/0.24) *
- #AD vs. HM (from ypT3-ypT4) (0.71/0.71) (0.55/0.42) * (0.32/0.31) (0.33/0.27)